Novo Nordisk - ADR NVO
Dividend Summary
The next Novo Nordisk - ADR dividend is expected to go ex in 4 months and to be paid in 4 months.
The previous Novo Nordisk - ADR dividend was 92.93c and it went ex 29 days ago and it was paid 18 days ago.
There are typically 2 dividends per year (excluding specials).
Latest Dividends
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | Forecast |
| Type | Final | Interim |
| Per share | 92.93c | Sign Up Required |
| Declaration date | 31 Jan 2024 (Wed) | – |
| Ex-div date | 22 Mar 2024 (Fri) | 19 Aug 2024 (Mon) |
| Pay date | 02 Apr 2024 (Tue) | 27 Aug 2024 (Tue) |
Enter the number of Novo Nordisk - ADR shares you hold and we'll calculate your dividend payments:
Previous Payment
$92.93
Paid on 02 Apr 2024 (Tue)
Free Email Notification
Sign up for Novo Nordisk - ADR and we'll email you the dividend information when they declare.
Add Novo Nordisk - ADR to receive free notifications when they declare their dividends.
Your account is set up to receive Novo Nordisk - ADR notifications.
The table below shows the full dividend history for Novo Nordisk - ADR
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Forecast | Final | – | 26 Mar 2029 | 03 Apr 2029 | USD | Sign up | — | |
| Forecast | Interim | – | 21 Aug 2028 | 22 Aug 2028 | USD | Sign up | — | |
| Forecast | Final | – | 27 Mar 2028 | 04 Apr 2028 | USD | Sign up | — | |
| Forecast | Interim | – | 16 Aug 2027 | 24 Aug 2027 | USD | Sign up | — | |
| Forecast | Final | – | 29 Mar 2027 | 06 Apr 2027 | USD | Sign up | — | |
| Forecast | Interim | – | 17 Aug 2026 | 25 Aug 2026 | USD | Sign up | — | |
| Forecast | Final | – | 30 Mar 2026 | 07 Apr 2026 | USD | Sign up | — | |
| Forecast | Interim | – | 18 Aug 2025 | 26 Aug 2025 | USD | Sign up | — | |
| Forecast | Final | – | 24 Mar 2025 | 08 Apr 2025 | USD | Sign up | — | |
| Forecast | Interim | – | 19 Aug 2024 | 27 Aug 2024 | USD | Sign up | — | |
| Paid | Final | 31 Jan 2024 | 22 Mar 2024 | 02 Apr 2024 | USD | 93.1c | 92.93c | 😄 |
| Paid | Interim | 10 Aug 2023 | 18 Aug 2023 | 29 Aug 2023 | USD | 72.18c | 72.18c | 😄 |
| Paid | Final | 02 Feb 2023 | 24 Mar 2023 | 04 Apr 2023 | USD | 114.62c | 118.06c | 😃 |
| Paid | Interim | 04 Aug 2022 | 12 Aug 2022 | 23 Aug 2022 | USD | — | 57.77c | |
| Paid | Final | 02 Mar 2022 | 25 Mar 2022 | 05 Apr 2022 | USD | — | 102.24c | |
| Paid | Interim | – | 16 Aug 2021 | 25 Aug 2021 | USD | — | 55.03c | |
| Paid | Final | – | 26 Mar 2021 | 07 Apr 2021 | USD | — | 92.21c | |
| Paid | Interim | 06 Aug 2020 | 14 Aug 2020 | 25 Aug 2020 | USD | — | 51.78c | |
| Paid | Final | 06 Feb 2020 | 27 Mar 2020 | 07 Apr 2020 | USD | — | 78.26c | |
| Paid | Interim | 09 Aug 2019 | 16 Aug 2019 | 27 Aug 2019 | USD | — | 44.94c | |
| Paid | Final | 26 Mar 2019 | 22 Mar 2019 | 02 Apr 2019 | USD | — | 77.7c | |
| Paid | Interim | 21 Aug 2018 | 17 Aug 2018 | 28 Aug 2018 | USD | — | 46.23c | |
| Paid | Final | – | 23 Mar 2018 | 03 Apr 2018 | USD | — | 80.6c | |
| Paid | Interim | – | 17 Aug 2017 | 29 Aug 2017 | USD | — | 47.38c | |
| Paid | Final | – | 23 Mar 2017 | 04 Apr 2017 | USD | — | 67.04c | |
| Paid | Interim | – | 11 Aug 2016 | 23 Aug 2016 | USD | — | 45.35c | |
| Paid | Final | 23 Mar 2016 | 18 Mar 2016 | 30 Mar 2016 | USD | — | 95.81c | |
| Paid | Final | 10 Feb 2015 | 19 Mar 2015 | 31 Mar 2015 | USD | — | 73c | |
| Paid | Final | 13 Mar 2014 | 21 Mar 2014 | 02 Apr 2014 | USD | — | 83.03c | |
| Paid | Final | 26 Feb 2013 | 21 Mar 2013 | 02 Apr 2013 | USD | — | 310.18c |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0c | — |
| 2007 | 0.0c | 0% |
| 2008 | 0.0c | 0% |
| 2009 | 0.0c | 0% |
| 2010 | 0.0c | 0% |
| 2011 | 0.0c | 0% |
| 2012 | 310.18c | 100% |
| 2013 | 83.03c | -73.2% |
| 2014 | 73.0c | -12.1% |
| 2015 | 95.81c | 31.2% |
| 2016 | 112.39c | 17.3% |
| 2017 | 127.98c | 13.9% |
| 2018 | 123.93c | -3.2% |
| 2019 | 123.2c | -0.6% |
| 2020 | 143.99c | 16.9% |
| 2021 | 157.27c | 9.2% |
| 2022 | 175.83c | 11.8% |
| 2023 | 165.11c | -6.1% |
| 2024 | Sign Up Required | |
| 2025 | Sign Up Required | |
| 2026 | Sign Up Required | |
| 2027 | Sign Up Required | |
| 2028 | Sign Up Required | |
Novo Nordisk Optimized Dividend Chart
The chart below shows the optimized dividends for this security over a rolling 12-month period.
- Dividend Yield Today
- 1.4%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 2.1% on 29 February 2024
- 52 Week Low
- 0.6% on 13 September 2023
- Next Ex-Div-Date Countdown
- Sign Up Required
About Novo Nordisk
Novo Nordisk is a pharmaceutical company focussed on diabetes treatment. It also operates in haemostasis management, growth hormone therapy and hormone replacement therapy. It employs over 26,000 people across 79 countries and markets its products in 180 countries.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- United States
- Share Price
- $122.71 (yesterday's closing price)
- Shares in Issue
- 3,435 million
- Market Cap
- $421.5bn
- 0
- Market Indices
- none
- Other listings
- Novo Nordisk, Novo Nordisk - Class B Shares
- Investor Relations URL
- Sign Up Required
- Home Page URL
- https://www.novonordisk.com/
- Dividend History URL
- Sign Up Required
- Financial Calendar URL
- Sign Up Required
Effectiveness and Issues of Celebrity Endorsement in Global Pharmaceutical Industry: Novo Nordisk Case
Celebrity endorsement in the global pharmaceutical industry has always been a controversial subject. On the one hand, celebrity promotion enables millions of people to get awareness of the medication suitable for their existing health needs. On the other hand, celebrity promotion presents a set of regulatory and ethical problems that can cause detrimental harm by replacing professional medical advice with unscientific personal testimonials.Â
